Avacta, ADC Theraputics sign collaboration and option agreement
The partnership will focus on developing potent Affimer-drug conjugates.
Read More
Tag: Affimer
Avacta, Glythera link to develop drug conjugates
UK companies Avacta and Glythera have sealed a licensing deal to develop drug conjugates using their combined technologies.
Read More
- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
